LEWISBERRY, Pa., Nov. 15, 2010 /PRNewswire/ -- Unilife Corporation ("Unilife" or "Company") (Nasdaq: UNIS; ASX: UNS) today announced that it has commenced U.S. sales of its Unitract® range of 1mL safety syringes.
Unilife and Independent Medical Co-Op, Inc. ("IMCO"), one of the largest medical supply co-operatives in the U.S., have entered into a preferred, non-exclusive marketing program for the sale of Unitract 1mL syringes to U.S. healthcare facilities.
IMCO's member distributors provide medical equipment and supplies to healthcare facilities across the U.S. and Canada. Many of IMCO's Members focus primarily on the physician and long-term care markets. These two segments of the U.S. healthcare market consume a significant proportion of all 1mL safety syringes manufactured each year.
Unilife considers IMCO to be an ideal partner to support the initial launch of its Unitract range of 1mL syringes in the U.S. It is now processing for shipment a number of initial purchase orders it has received from IMCO member distributors. Discussions with a number of additional IMCO members are currently under way as part of an integrated nationwide launch for the Company's FDA-certified range of products.
Mr. Alan Shortall, CEO of Unilife, stated, "Unilife is delighted to announce the commencement of U.S. sales and shipments for its Unitract range of 1mL syringes. It is appropriate that U.S. sales have commenced in the same month that healthcare industry leaders are celebrating the 10-year anniversary of the signing of the Federal Needlestick Safety and Prevention Act. Despite these laws mandating the use of safety syringes within U.S. healthcare facilities, many healthcare workers continue to remain at risk of needlestick injury, including injuries from existing safety syringe technologies. We believe the automatic and operator controlled safety features